Stock TSVT 2SEVENTY BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart 2seventy bio, Inc.

Equities

TSVT

US9013841070

Delayed Nasdaq
Other stock markets
 13:00:00 2024-07-03 EDT 		5-day change 1st Jan Change
4.01 USD +3.89% Intraday chart for 2seventy bio, Inc. +11.39% -6.09%
06-26 2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours MT
06-26 2seventy Bio Sells Gene Editing Therapy To Novo Nordisk for Up To $40 Million DJ
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
2SEVENTY BIO, INC. Stock 2seventy bio, Inc.
 206M - - -
MODERNA, INC. Stock Moderna, Inc.
 44.44B -
LONZA GROUP AG Stock Lonza Group AG
 39.84B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 37.68B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 31.46B -
CELLTRION, INC. Stock Celltrion, Inc.
 27.02B
  1. Stock Market
  2. Equities
  3. TSVT Stock
  4. Charts 2seventy bio, Inc.
  5. Sector Chart